PL4551221T3 - Związek do leczenia dysfunkcji seksualnych u samic/kobiet - Google Patents
Związek do leczenia dysfunkcji seksualnych u samic/kobietInfo
- Publication number
- PL4551221T3 PL4551221T3 PL23735068.1T PL23735068T PL4551221T3 PL 4551221 T3 PL4551221 T3 PL 4551221T3 PL 23735068 T PL23735068 T PL 23735068T PL 4551221 T3 PL4551221 T3 PL 4551221T3
- Authority
- PL
- Poland
- Prior art keywords
- compound
- treatment
- sexual dysfunction
- female sexual
- female
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22183862 | 2022-07-08 | ||
| PCT/EP2023/068583 WO2024008808A1 (en) | 2022-07-08 | 2023-07-05 | Compound for treatment of female sexual dysfunction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4551221T3 true PL4551221T3 (pl) | 2026-04-20 |
Family
ID=82403816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL23735068.1T PL4551221T3 (pl) | 2022-07-08 | 2023-07-05 | Związek do leczenia dysfunkcji seksualnych u samic/kobiet |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP4551221B1 (pl) |
| JP (1) | JP2025522944A (pl) |
| KR (1) | KR20250030479A (pl) |
| CN (1) | CN119584965A (pl) |
| AU (1) | AU2023303077A1 (pl) |
| CA (1) | CA3259792A1 (pl) |
| ES (1) | ES3065421T3 (pl) |
| IL (1) | IL318065A (pl) |
| MX (1) | MX2024015768A (pl) |
| PL (1) | PL4551221T3 (pl) |
| TW (1) | TW202409027A (pl) |
| WO (1) | WO2024008808A1 (pl) |
| ZA (1) | ZA202409552B (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025051846A1 (en) * | 2023-09-05 | 2025-03-13 | Initiator Pharma A/S | Compound for treatment of female sexual dysfunction |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU702720B2 (en) | 1995-11-02 | 1999-03-04 | Neurosearch A/S | Fused tropane-derivatives as neurotransmitter reuptake inhibitors |
| BR9707636A (pt) | 1996-02-22 | 1999-07-27 | Neurosearch As | Composto composição farmacêutica uso de um composto e processos para preparar composto e para tratar um distúrbio ou doença de um organismo animal vivo |
| WO2011092061A1 (en) | 2010-01-29 | 2011-08-04 | Neurosearch A/S | Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
-
2023
- 2023-07-05 PL PL23735068.1T patent/PL4551221T3/pl unknown
- 2023-07-05 AU AU2023303077A patent/AU2023303077A1/en active Pending
- 2023-07-05 IL IL318065A patent/IL318065A/en unknown
- 2023-07-05 CA CA3259792A patent/CA3259792A1/en active Pending
- 2023-07-05 TW TW112125110A patent/TW202409027A/zh unknown
- 2023-07-05 ES ES23735068T patent/ES3065421T3/es active Active
- 2023-07-05 KR KR1020257002007A patent/KR20250030479A/ko active Pending
- 2023-07-05 EP EP23735068.1A patent/EP4551221B1/en active Active
- 2023-07-05 WO PCT/EP2023/068583 patent/WO2024008808A1/en not_active Ceased
- 2023-07-05 CN CN202380052608.6A patent/CN119584965A/zh active Pending
- 2023-07-05 JP JP2025500758A patent/JP2025522944A/ja active Pending
-
2024
- 2024-12-11 ZA ZA2024/09552A patent/ZA202409552B/en unknown
- 2024-12-17 MX MX2024015768A patent/MX2024015768A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20250030479A (ko) | 2025-03-05 |
| EP4551221C0 (en) | 2026-02-18 |
| MX2024015768A (es) | 2025-04-02 |
| TW202409027A (zh) | 2024-03-01 |
| AU2023303077A1 (en) | 2025-02-06 |
| JP2025522944A (ja) | 2025-07-17 |
| CN119584965A (zh) | 2025-03-07 |
| CA3259792A1 (en) | 2024-01-11 |
| EP4551221B1 (en) | 2026-02-18 |
| ZA202409552B (en) | 2025-08-27 |
| ES3065421T3 (en) | 2026-05-06 |
| WO2024008808A1 (en) | 2024-01-11 |
| EP4551221A1 (en) | 2025-05-14 |
| IL318065A (en) | 2025-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL315896A (en) | Cognitive function therapy | |
| ES3065421T3 (en) | Compound for treatment of female sexual dysfunction | |
| IL315503A (en) | Treatment methods | |
| IL320711A (en) | Treatment methods | |
| GB202201824D0 (en) | Methods of treatment | |
| HK40119817A (en) | Compound for treatment of female sexual dysfunction | |
| GB202219778D0 (en) | Treatment of female sexual dysfunction | |
| GB202400024D0 (en) | Treatment of female sexual dysfunction | |
| HK40128984A (en) | Compound for treatment of erectile dysfunction | |
| CA3278871A1 (en) | Compound for treatment of erectile dysfunction | |
| GB202201819D0 (en) | Methods of treatment | |
| GB202201825D0 (en) | Methods of treatment | |
| GB202317980D0 (en) | Treatment of erectile dysfunction | |
| GB202317987D0 (en) | Treatment of erectile dysfunction | |
| GB202317983D0 (en) | Treatment of erectile dysfunction | |
| GB202313352D0 (en) | Treatment of erectile dysfunction | |
| GB202313351D0 (en) | Treatment of erectile dysfunction | |
| GB202313346D0 (en) | Treatment of erectile dysfunction | |
| GB202313350D0 (en) | Treatment of erectile dysfunction | |
| GB202217711D0 (en) | Treatment of erectile dysfunction | |
| GB202217712D0 (en) | Treatment of erectile dysfunction | |
| GB202212742D0 (en) | Treatment of erectile dysfunction | |
| GB202212736D0 (en) | Treatment of erectile dysfunction | |
| GB202212740D0 (en) | Treatment of erectile dysfunction | |
| GB202212739D0 (en) | Treatment of erectile dysfunction |